Robert G. Savage
Directeur Général chez Strategic Imagery LLC
Profil
Robert G.
Savage is currently the Chairman, President & Chief Executive Officer at Strategic Imagery LLC.
He previously served as the Chairman-Worldwide Pharmaceuticals Group at Johnson & Johnson from 1996 to 2002.
He was also the Chairman at NovaDel Pharma, Inc. Additionally, he held positions as an Independent Director at Savient Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Assertio Therapeutics, Inc., The Medicines Co., and Humanigen, Inc. He served as a Director at EpiCept Corp., Nuovo Biologics LLC, Panacos Pharmaceuticals, Inc., EpiCept Corp., and Bexion Pharmaceuticals, Inc. He was an Independent Director at MergeWorthRx Corp.
He started his career as the Vice President-Marketing at Hoffmann-La Roche, Inc. and later became the President at Ortho-McNeil Pharmaceutical LLC.
He also served as the President-General Therapeutics at Pharmacia Corp.
Mr. Savage holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Upsala College.
Postes actifs de Robert G. Savage
| Sociétés | Poste | Début |
|---|---|---|
| Strategic Imagery LLC | Directeur Général | 01/05/2003 |
Anciens postes connus de Robert G. Savage
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Directeur/Membre du Conseil | 01/01/2021 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Directeur/Membre du Conseil | 15/08/2017 |
| THE MEDICINES COMPANY | Directeur/Membre du Conseil | 14/08/2016 |
| MERGEWORTHRX CORP | Directeur/Membre du Conseil | 01/01/2015 |
| SAVIENT PHARMACEUTICALS INC | Directeur/Membre du Conseil | 08/01/2014 |
Formation de Robert G. Savage
| Rutgers State University of New Jersey | Masters Business Admin |
| Upsala College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
NovaDel Pharma, Inc.
 NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
EpiCept Corp. /Old/
 EpiCept Corp. /Old/ Pharmaceuticals: MajorHealth Technology EpiCept Corporation is a specialty pharmaceutical company focused on the development and commercialization of topically-delivered prescription pain management therapeutics. EpiCept has six products in clinical development for the treatment of various types of pain: three are ready to enter, or have entered, pivotal Phase IIb or Phase III clinical trials | Health Technology |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
| Strategic Imagery LLC | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Nuovo Biologics LLC
 Nuovo Biologics LLC BiotechnologyHealth Technology Nuovo Biologics LLC commercializes and distributes protein drugs. Its drug formulation provides treatment for herpes, influenza, and retroviruses. The firm's products include PVX, an antiviral and MMX, an antitumor formulation. The company was founded by Jay E. Yourist in 2010 and is headquartered in Miami, FL. | Health Technology |
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
MergeWorthRx Corp.
 MergeWorthRx Corp. Finance/Rental/LeasingFinance MergeWorthRx Corp. operates as a acquisition company. The company's purpose is to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses or entities. It expects to focus on the United States healthcare industry. The company was founded by Anthony Minnuto, Charles F. Fistel and Stephen B. Cichy on January 22, 2013 and is headquartered in Miami, FL. | Finance |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Health Technology |
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Commercial Services |
